Last updated 2026-10-28
- Raised $60M Public Offering, Jun 2020
- Raised $50M Series F led by existing shareholders, Sep 2019
- Raised $65M Series D led by Apple Core Holdings, Oct 2018
Total raised
$241.5M
Last: Public Offering 2025-06
Stage
Public
Founded
2008
Headcount
83
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
PolyPid is a late-stage biopharmaceutical company focused on improving surgical outcomes through its proprietary PLEX (Polymer-Lipid Encapsulation matriX) and Kynatrix™ technologies. These technologies enable the precise, controlled, and prolonged release of therapeutics, delivering drugs at optimal rates over extended durations. The company's lead product candidate, D-PLEX100, is in a phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. Additionally, PolyPid is developing OncoPLEX, which is in preclinical testing for treating solid tumors, including glioblastomas, and PD01B for diabetic foot infections.
Funding history · 10 rounds · $241.5M total
10 events/rounds · $241.5M Total Funding: $157.8M in Private Equity, $83.7M in Public Equity
Nov 2025
Public Offering
$15.0M
EDGAR filing SEC-EDGAR 424B5
May 2023
Public Offering
$8.7M
EDGAR filing SEC-EDGAR 424B5
Jun 2020
Public Offering
$60.0M
EDGAR filing SEC-EDGAR 424B4
Sep 2019
★ existing shareholders★ Unspecified institutional shareholdersAurumUS investorsShavit CapitalCHealth VenturesFriendly Angels Club groupUS-based high-net-worth investorsExisting institutional shareholders
Nov 2018
★ Shareholders★ Shareholders and new investors
Oct 2018
★ Apple Core Holdings
Feb 2016
Dec 2012
Jan 2012
Jan 2010
Seed
$1.4M
globes.co.il
Offices
Petah Tikva, Israel · HQ / main office
Q&A
- What is PolyPid's primary focus?
- PolyPid is a late-stage biopharmaceutical company focused on improving surgical outcomes through its proprietary PLEX (Polymer-Lipid Encapsulation matriX) and Kynatrix™ technologies, which enable controlled and prolonged release of therapeutics.
- What is PolyPid's lead product candidate and its current development stage?
- PolyPid's lead product candidate, D-PLEX100, is in a phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections.
- When was PolyPid founded and where is its headquarters located?
- PolyPid was founded in February 2008 and is headquartered in Petah Tikva, Israel.
- What was PolyPid's most recent public offering?
- In November 2025, PolyPid had a public offering that raised $15,000,000.
- What was the amount and lead investors of PolyPid's C Round funding?
- In February 2016, PolyPid raised $22,000,000 in a C Round, with lead investors Shavit Capital.
- What other products is PolyPid developing?
- PolyPid is developing OncoPLEX, which is in preclinical testing for treating solid tumors including glioblastomas, and PD01B for diabetic foot infections.
- What was the total amount raised by PolyPid through funding rounds?
- PolyPid has raised a total of $241,506,775 across all funding rounds.
Team · 16
Noam Emanuel
Founder · Co-founder and Chief Scientific Officer
Dikla Czaczkes Akselbrad
Chief Executive Officer
Dalit Fellous Hazan
Deputy CEO, EVP R&D, Clinical, and Regulatory Affairs
Ori Warshavsky
Chief Operating Officer - US
Jean-Marc Hagai
Chief Commercial Officer
Jonny Missulawin
Chief Financial Officer
Tal Vilnai
General Counsel & Corporate Secretary
Maria Rubin
EVP, Operations
Rivi Lev-Ari
VP, Human Resources
Nurit Tweezer-Zaks
Chief Medical Officer
Brooke Story
Chairman of the Board of Directors
Yechezkel Barenholz
Independent Non-Employee Director
Itzhak Krinsky
Independent Non-Employee Director
Nir Dror
Independent Non-Employee Director
Joseph BenAmram
Independent Non-Employee Director
Robert B. Stein
Independent Non-Employee Director
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Highlights
Patents
Tags
orthopedicsdentaldrug-deliverypharma-companiessustained-releasetherapeuticspain-reliefcancerbiopharmaceuticalsurgeonshealth-techlife-sciences
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | polypid.com |
|---|---|
| linkedin.com/company/3835371 |
Identifiers & details
| Legal name | PolyPid Ltd. |
|---|---|
| Founded | 2008-2 |
| Employees (exact) | 83 |
Radar intelligence
Patents
| EPO | 13 |
|---|
Publications (Crossref)
| Works | 8 |
|---|
Web history (Wayback)
| Domain | polypid.com |
|---|
Certificate / subdomain footprint
| Subdomains | 11 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514105923 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 2008-02-24 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2021 |
| Active charges / liens | 0 |
| Registry events | 3 — people (3) |
| Registered address | הסיבים 18 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-15 | עדכון דירקטורים-הוספת דירקטור |
| 2026-06-15 | עדכון דירקטורים-הסרת דירקטור |
| 2026-06-14 | עדכון בעלי תפקידים |